tiprankstipranks
Clovis Oncology (CLVSQ)
OTHER OTC:CLVSQ
Holding CLVSQ?
Track your performance easily

Clovis Oncology (CLVSQ) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
3Neutral
7Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Clovis Oncology’s (CLVSQ) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Clovis Oncology is a Buy.
Clovis Oncology’s (CLVSQ) 20-Day exponential moving average is 0.02, while Clovis Oncology’s (CLVSQ) share price is <$0.1, making it a Buy.
Clovis Oncology’s (CLVSQ) 50-Day exponential moving average is 0.03, while Clovis Oncology’s (CLVSQ) share price is <$0.1, making it a Sell.

Clovis Oncology (CLVSQ) Pivot Points

Nov 20, 2024, 10:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
<0.01
<0.01
<0.01
0.01
0.01
0.01
0.01
Fibonacci
<0.01
<0.01
<0.01
0.01
0.01
0.01
0.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Clovis Oncology (CLVSQ) Moving Averages

Nov 20, 2024, 10:47 PM
Period
Simple
Exponential
MA5
0.01Buy
0.02Buy
MA10
0.02Buy
0.02Buy
MA20
0.02Buy
0.02Buy
MA50
0.03Sell
0.03Sell
MA100
0.05Sell
0.10Sell
MA200
0.27Sell
0.39Sell
Clovis Oncology’s (CLVSQ) 10-Day exponential moving average is 0.02, while Clovis Oncology’s (CLVSQ) share price is <$0.1, making it a Buy.
Clovis Oncology’s (CLVSQ) 100-Day exponential moving average is 0.10, while Clovis Oncology’s (CLVSQ) share price is <$0.1, making it a Sell.
Clovis Oncology’s (CLVSQ) stock price is <$0.1 and Clovis Oncology’s (CLVSQ) 50-day simple moving average is 0.03, creating a Sell signal.
Clovis Oncology’s (CLVSQ) stock price is <$0.1 and Clovis Oncology’s (CLVSQ) 100-day simple moving average is 0.05, creating a Sell signal.
Clovis Oncology’s (CLVSQ) stock price is <$0.1 and Clovis Oncology’s (CLVSQ) 200-day simple moving average is 0.27, creating a Sell signal.

Clovis Oncology (CLVSQ) Technical Indicators

Nov 20, 2024, 10:47 PM
Name
Value
Implied Action
RSI (14)
48.15
Neutral
STOCH (9,6)
16.67
Buy
STOCHRSI (14)
16.67
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
17.11
Buy
Williams %R
-50.00
Buy
CCI (14)
-80.24
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
50.90
Neutral
ROC
0.00
-
Clovis Oncology’s (CLVSQ) Relative Strength Index (RSI) is 48.15, creating a Neutral signal.
Clovis Oncology’s (CLVSQ) Trend Strength Indicator (ADX) is 17.11, creating a Buy signal.
Clovis Oncology’s (CLVSQ) Commodity Channel Index (CCI) is -80.24, creating a Neutral signal.

FAQ

Is CLVSQ a Buy, Hold, or Sell?
Based on CLVSQ’s technical indicators, CLVSQ is a Buy.
    What is CLVSQ’s RSI (14)?
    CLVSQ’s RSI (14) is 48.15, which suggests CLVSQ is a Neutral.
      What is CLVSQ’s MACD?
      CLVSQ’s MACD is >-0.01, which suggests CLVSQ is a Buy.
        What is CLVSQ’s 5-day moving average?
        CLVSQ’s 5-day moving average is 0.01, which suggests CLVSQ is a Buy.
          What is CLVSQ’s 20-day moving average?
          CLVSQ 20-day moving average is 0.02, which suggests CLVSQ is a Buy.
            What is CLVSQ’s 50-day moving average?
            CLVSQ’s 50-day moving average is 0.03, which suggests CLVSQ is a Sell.
              What is CLVSQ’s 200-day moving average?
              CLVSQ’s 200-day moving average is 0.27, which suggests CLVSQ is a Sell.
                What is CLVSQ’s Williams % R (14)?
                CLVSQ’s Williams % R (14) is -50.00, which suggests CLVSQ is a Buy.
                  What is CLVSQ’s CCI (14)?
                  CLVSQ’s CCI (14) is -80.24, which suggests CLVSQ is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis